1 / 25

BENIGN (PEPTIC) STRICTURE

BENIGN (PEPTIC) STRICTURE. Group D Mamba - Medenilla. BENIGN (PEPTIC) STRICTURE. Peptic Stricture Results from fibrosis that causes luminal constriction. Source: p.1851. BENIGN (PEPTIC) STRICTURE. Clinical features. Diagnosis. General principles of Treatment. Clinical features.

wilton
Download Presentation

BENIGN (PEPTIC) STRICTURE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. BENIGN (PEPTIC) STRICTURE Group D Mamba - Medenilla

  2. BENIGN (PEPTIC) STRICTURE • Peptic Stricture • Results from fibrosis that causes luminal constriction Source: p.1851

  3. BENIGN (PEPTIC) STRICTURE Clinical features Diagnosis General principles of Treatment

  4. Clinical features Source: p.1851

  5. BENIGN (PEPTIC) STRICTUREClinical features Patient Benign Peptic Stricture • History • Difficulty of swallowing • Regurgitation of sour material • Chest pain after eating • Copious sputum upon waking up • Dysphagia to solid foods • Occasional vomiting of previously taken in food • Symptoms relieved by Omeprazole but would recur intermittently • Weight loss of 8 kg • History • Progressive dysphagia to solid food • Heartburn and chest pain • Odynophagia • Food impaction • Weight loss Esophageal stricture, http://emedicine.medscape.com/

  6. BENIGN (PEPTIC) STRICTUREClinical features Patient Benign Peptic Stricture • Physical exam • BMI: 17.63 kg/m^2 • Vital signs normal • Pulmonary: No crackles nor wheezes • Cardiac: Heart sounds unremarkable • Abdominal: scaphoid abdomen, non tender, no masses • Neurologic: no evident deficit • Physical exam • Physical examination frequently does not provide clues to the cause of dysphagia. • Assess nutritional status Esophageal stricture, http://emedicine.medscape.com/

  7. BENIGN (PEPTIC) STRICTURE Clinical features Diagnosis General principles of Treatment

  8. History Therapeutic Trial with a PPI (egomeprazole, 40 mg BID for 1 wk) Diagnosis Source: p.1851

  9. Barium swallow Barium swallow showing peptic stricture due to Gastro-esophageal reflux

  10. Barium Esophagram • Provides objective baseline information: • location, length • stricture diameter • esophageal wall consistency • irregularity • Complementary to endoscopic findings • May be more sensitive than endoscopy for detection of subtle narrowings of the esophagus • Diameter: > 10 mm • 100% sensitivity with luminal diameter <9 mm • 90% sensitivity with luminal diameter >10 mm

  11. 24-Hour pH Monitoring • Identifies the presence and extent of reflux • Helpful in evaluating and documenting the adequacy of therapy in patients who remain symptomatic despite treatment with PPIs or fundoplication

  12. Histologic Findings • Initial histologic changes in the peptic stricture process • Edema, cellular infiltration, basal cell hyperplasia, and vascular changes with a slight increase in type III collagen deposition on healing • If untreated, the process can lead to progressive inflammation and ulceration involving the submucosa and muscularis mucosa • Muscular layer and intrinsic nervous system damage of the esophagus Type I Collagen deposition  Scar tissue and stricture formation

  13. BENIGN (PEPTIC) STRICTURE Clinical features Diagnosis General principles of Treatment

  14. For patients [with GERD] + associated peptic stricture General principles of Treatment Source: p.1852

  15. Pretreatment Classification • Consider severity of the condition and complications following treatment • preoperative evaluation, preoperative and pretreatment assessment of the patient, as well as the character of the stricture.

  16. Medical Care • more emphasis has been placed on mechanical dilatation • coexistent esophagitis has been relatively ignored • several studies have demonstrated that aggressive acid suppression using PPIs is extremely beneficial in the initial treatment, as well as long-term management.

  17. Medical Care • Studies have shown that aggressive acid-suppression therapy with PPIs both improve esophagitis and decrease the need for subsequent esophageal dilatation • PPI therapy has to be individualized, depending on the level of reduction in acid exposure as assessed by 24-hour pH monitoring.

  18. PPI’s Omeprazole (Prilosec) Decreases gastric acid secretion by inhibiting the parietal cell H+/K+ -ATP pump. Adult : 20 mg PO qam 30 min ac; may increase bid Lansoprazole (Prevacid) Suppresses gastric acid secretion by specifically inhibiting H+/K+- ATPase enzyme system at the secretory surface of gastric parietal cells. Adult : 30 mg PO qam 30 min ac; may increase to 30 mg bid Rabeprazole (Aciphex) Decreases gastric acid secretion by inhibiting the parietal cell H+/K+ ATP pump. Adult :20 mg PO qam 30 min ac; may increase to 20 mg PO bid if necessary

  19. PPI’s Pantoprazole (Protonix) Decreases gastric acid secretion by inhibiting the parietal cell H+/K+ ATP pump. Adult : 40 mg PO qam 30 min ac; may increase to bid Esomeprazole magnesium (Nexium) S-isomer of omeprazole. Inhibits gastric acid secretion by inhibiting H+/K+ -ATPase enzyme system at secretory surface of gastric parietal cells. Adult : 20-40 mg PO qd for 4-8 wk

  20. Surgical Care (endoscopic and surgical modalities ) • choice of dilator and technique is dependent on many factors, the most important being stricture characteristics • factors, including patient tolerance, operator preference, and experience. • dilatation therapy should be tailored individually

  21. Endoscopic Therapy • Three types: • mercury field bougies • polyvinyl bougies • balloon dilators • Usually the physician passes a series of dilators or gradually increases the diameter of the balloon to stretch out the stricture. • complications such as perforation and bleeding occurred in approximately 0.5% of all esophageal dilation procedures

  22. Surgical Therapy • Conservative antireflux surgery with classic fundoplication has been employed for peptic stricture patients with a long-term success rate ranging from 65 to 90%. • laparoscopic approach report a 12% failure rate, whereas others demonstrate significantly higher recurrence rates (25%). • esophageal lengthening gastroplasty of the Collies-Nissen type or Collies-Belsey Mark IV type have been proposed

  23. Surgical Therapy • More mutilating surgical procedures, incorporating partial gastrectomy, vagotomy with or without biliary diversion, or duodenal switch procedures have been introduced. • Esophageal resection has been proposed in patients with severe stricture, poor contractility, or high-grade dysplasia.

  24. BENIGN (PEPTIC) STRICTURENon-pharmacologic treatment Diet • Avoid fatty and spicy foods, alcohol, tobacco, chocolate, and peppermint. • Not to eat at least 2-3 hours before bedtime. •  Should eat smaller meals, avoid eating in a hurried fashion, and chew their food well. •  Weight reduction •  Ill-fitting dentures or poor dentition should be corrected if possible.

More Related